Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2255studies indexed1010with human data129registered trials1946carry a numeric findingLibrarian added 23 studies today
Showing 17 studiesSortNewest indexed
B
grade
Effects of the combination therapy of hemodialysis with hemoperfusion on medium molecular toxins and protein bound uremic toxins in maintenance hemodialysis patients.
Zenagamtide · Blood purification · 2026 · Observational · n=38
Combining hemodialysis with hemoperfusion significantly reduces certain toxins in dialysis patients, but further research is needed to confirm optimal treatment frequency.
β2-MG reduced from 29.72±5.61 to 21.50±6.69 μg/ml, t=5.882, P<0.001
A
grade
Effects of remimazolam vs. propofol on plasma neurofilament light chain and postoperative delirium in frail elderly patients undergoing major non-cardiac surgery: a prospective, randomized, assessor-blinded controlled trial.
Zenagamtide · BMC anesthesiology · 2026 · RCT · Phase 4 · n=123
In frail elderly patients undergoing major non-cardiac surgery, remimazolam does not show significant advantages over propofol in reducing plasma neurofilament levels or postoperative delirium incidence, though it may offer better hemodynamic stability.
Plasma NfL concentrations on postoperative day 1 were 123.3[83.6-198.2] pg/ml for Group R and 149.0[102.0-226.6] pg/ml for Group P, P=0.186.
B
grade
Renal Impairment Does Not Affect Pharmacokinetics, Safety or Tolerability of Zenagamtide.
Zenagamtide · Diabetes, obesity & metabolism · 2026 · Observational · Phase 1 · n=42High-impact journal
Renal impairment does not appear to significantly affect the pharmacokinetics or safety of zenagamtide, indicating no need for dose adjustment in these patients.
AUC0-∞ ranged from 520-715 h × nmol/L across renal impairment groups versus 543 h × nmol/L for normal renal function group.
B
grade
Haemophilus abundance is associated with response to sublingual immunotherapy in children with allergic rhinitis.
Zenagamtide · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023 · Observational · n=63
Elevated nasal Haemophilus levels are linked to more severe allergic rhinitis in children, and its reduction after treatment may indicate a positive response to sublingual immunotherapy.
LDA score >4, p<0.001 for Proteobacteria abundance in MSAR patients.
A
grade
Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.
Zenagamtide · Lancet (London, England) · 2024 · RCT · Phase 2 · n=186Top journal
Zenagamtide showed significant reductions in HbA1c levels in adults with type 2 diabetes at all tested doses, but the clinical relevance of these changes should be carefully evaluated.
Estimated mean change in HbA1c was -1.4% with zenagamtide 50 mg (ETD vs placebo -1.09%, 95% CI -1.59 to -0.59; p<0.0001).
A
grade
Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.
Zenagamtide · Lancet (London, England) · 2024 · RCT · Phase 2 · n=915Top journal
Zenagamtide demonstrated statistically significant reductions in HbA1c in adults with type 2 diabetes, but the clinical relevance of these findings, particularly at lower doses, remains uncertain.
Estimated change in HbA1c at week 36 ranged from -0.9% with zenagamtide 0.4 mg to -1.7% with zenagamtide 40 mg.
B
grade
Self-reported versus clinician-evaluated symptom assessment and diagnosis of ICD-11 PTSD and CPTSD: a comparison between the International Trauma Interview and the International Trauma Questionnaire.
Zenagamtide · European journal of psychotraumatology · 2026 · Observational · n=108
The ITQ can effectively screen for trauma-related psychopathology, but it should not replace comprehensive clinical interviews for diagnosing PTSD or CPTSD.
Total symptom scores for PTSD, DSO, and CPTSD showed strong associations between instruments (r = .74 to .82, all p < .001).
Showing 17 of 17